797167--4/15/2008--NATURADE_INC

related topics
{stock, price, share}
{product, market, service}
{stock, price, operating}
{customer, product, revenue}
{personnel, key, retain}
{product, liability, claim}
{property, intellectual, protect}
{control, financial, internal}
{interest, director, officer}
{regulation, change, law}
{product, candidate, development}
{financial, litigation, operation}
{acquisition, growth, future}
{capital, credit, financial}
{condition, economic, financial}
On August 31, 2006 (the Petition Date ), the Company filed for protection under Chapter 11 of the U.S. Bankruptcy Code and emerged from bankruptcy on November 9 2007. The Company may incur future losses which may affect its ability to continue as The Company s success depends on current and ongoing financing which may not be available or, if available, could result in substantial dilution to its stockholders, depress the market price of its common stock and impair its ability to raise capital by selling its common stock The Company s current financial condition could cause third party suppliers and manufacturers to refuse to do business with us, or to do so only on less The Company s revenues depend on continued business from the Company s key If the Company s third-party suppliers or manufacturers fail to timely deliver products of acceptable quality or comply with FDA manufacturing guidelines, or raise prices, profits may be affected. Restrictions or requirements imposed by government regulation could result in material harm to the Company s results of operations and financial condition. The Company s competitors may develop products that are more effective or less The Company s success depends on its ability to attract and retain qualified Expanding the Company s sales in the mass market resulted in less stable demand for the Company s products and higher costs of distribution. One stockholder has the ability to control the Company. Future sales of equity securities could cause substantial dilution to the Company s stockholders depress the market price of its common stock and impair its ability to raise capital by selling its common stock. The Company s future success depends on the Company s ability to develop and The Company is subject to variability of quarterly results and, therefore, its results of operations for any period may not be indicative of future periods. The Company may not have sufficient resources to address product liability The Soy protein based foods category is experiencing a decline in sales. Adverse publicity may affect the Company s ability to attract and retain The Company may not be able to protect its intellectual property which could enable other companies to replicate its products. New products are expensive to introduce and may not be successful. The Company s stock price may be subject to significant fluctuations. The Company s common stock is currently deemed to be a penny stock. As a result, trading of its shares may be subject to special requirements which could impede the Company s stockholders ability to resell their shares.

Full 10-K form ▸

related documents
894536--5/4/2007--POWERLINX_INC
732412--3/31/2006--MULTIBAND_CORP
889423--3/12/2010--SATCON_TECHNOLOGY_CORP
1311318--4/1/2008--Lightspace_Corp
1311318--3/26/2007--Lightspace_Corp
902600--4/14/2006--AKSYS_LTD
1084000--6/13/2008--BIOPHAN_TECHNOLOGIES_INC
1019034--3/26/2010--BIO_KEY_INTERNATIONAL_INC
799097--4/17/2007--SAN_HOLDINGS_INC
277058--7/31/2006--NEVADA_GOLD_&_CASINOS_INC
1164554--3/16/2006--EUROBANCSHARES_INC
1164554--3/13/2008--EUROBANCSHARES_INC
1164554--3/16/2007--EUROBANCSHARES_INC
702513--3/5/2010--Bank_of_Commerce_Holdings
716101--4/17/2006--EQUITEX_INC
1418730--3/17/2010--Industry_Concept_Holdings_Inc
1418475--10/14/2008--T.O.D._TASTE_ON_DEMAND_INC
885317--3/31/2009--OPHTHALMIC_IMAGING_SYSTEMS
1090967--3/31/2008--GLOBAL_ENERGY_INC
1174820--3/12/2010--CENTER_FINANCIAL_CORP
1068084--3/17/2008--PRIVATE_MEDIA_GROUP_INC
1068084--4/2/2007--PRIVATE_MEDIA_GROUP_INC
75439--5/17/2010--CytoCore_Inc
716101--5/18/2007--HYDROGEN_POWER_INC
932781--3/29/2010--FIRST_COMMUNITY_CORP_/SC/
1159427--3/15/2006--SOUTHERN_COMMUNITY_FINANCIAL_CORP
889423--3/12/2009--SATCON_TECHNOLOGY_CORP
899426--3/31/2008--CALYPTE_BIOMEDICAL_CORP
1331520--3/6/2009--HOME_BANCSHARES_INC
1108891--7/14/2009--LIGHTSCAPE_TECHNOLOGIES_INC.